Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Takeda

Takeda launches 'first-of-its-kind' global observational study

07-Sep-2016 - The open-source study was launched in order to advance understanding of real-world experience with therapies and clinical outcomes in patients with multiple myeloma.

Research consortium looks to identify biomarkers for autism treatments

21-Jul-2015 - A new four-year research project involving a consortium of government, non-profit and other large biopharma partners is aiming to create a set of measures that can be used in clinical...

Takeda looks to BioXcel to help repurpose old assets for new rare disease indications

09-Apr-2015 - Takeda’s development center in the US has agreed to partner with BioXcel, a cloud-based big data solution provider, to repurpose old medicines to help treat rare diseases. 

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

Russia set for first foreign CMOs as pharma preps for 2020 policy

09-Jul-2014 - Several international CMOs will establish themselves in Russia over the next few years as pharma looks to satisfy the country's manufacturing policies, the CEO of R-Pharm predicts.

ADC pipelines drive single-use expansion at Lonza's clinical facility

11-Jun-2014 - Lonza has invested in single-use technology at its Swiss clinical manufacturing facility citing a rise in demand as customer’s grow their antibody-drug conjugate (ADC) pipelines.

AMRI to focus on scale and capabilities of API biz following robust 2013

17-Feb-2014 - AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.

AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy

13-Jan-2014 - AMEC has announced its plan to buy US  firm Foster Wheeler AG for $3.2bn (€2.3bn) in a deal that includes the latter’s pharmaceutical plant design services business.

Carbogen Amcis CEO: Competition in ADC sector not a concern

04-Oct-2013 - Investing in antibody-drug conjugates (ADCs) made sense despite CMO competition and the fact few of these hybrid drugs have been approved to date says Carbogen Amcis CEO, Mark Griffiths....

Pfizer Selects Sanford-Burnham for Diabetes Drug Discovery

20-Aug-2013 - Over the next three years Pfizer will work with the Sanford Burnham Medical Research Institute to discover therapeutic targets to prevent and treat complications related to obesity and diabetes.

Russian Protectionism may Offer Chances For Local CMOs, Expert Says

15-Jul-2013 - Pharma may be "wary of making big investments" in the protected Russian market leaving an opportunity for local CMOs, according to an industry expert.

People on the Move: Outsourcing Jobs

06-Jun-2013 - presents its latest round-up of the movers and shakers in the pharma service industry.

Takeda Cracks Down on CMO Plant Suspended After Manufacturing Violation

19-Feb-2013 - Takeda says it will help Nihon Pharmaceuticals bring manufacturing operations up to code after Japanese regulators order the CMO to halt production and recall one lot of its vitamin B1...

Takeda enters into partnership with Quintiles and Covance

16-Feb-2011 - Takeda Pharmaceuticals has joined the growing list of pharma companies to forge strategic deals with contract research organisations (CRO) by signing new deals with Covance and Quintiles.

Takeda pursues CMO in court for $26.7m

15-Sep-2008 - Takeda Pharmaceutical has filed a lawsuit in an attempt to recoup $26.7m in damages, after it had to recall a product made by a contract manufacturing organisation (CMO).

Takeda sleeping drug takes 'Worst Product Award'

30-Oct-2007 - Japanese pharma firm Takeda beat off strong competition from the likes of Coca-Cola to take home the dubious honour of Consumer International's 'Worst Product' award thanks to its sleeping pill...

Takeda acquires next-gen diabetes treatment rights

14-Jul-2005 - Pharmaceutical company, Takeda, has struck a deal with pharmaceutical services provider, PPD, in which it has acquired the rights to all dipeptidyl peptidase IV (DPP4) inhibitors - one of a...

Takeda licenses 'first chemoprotective drug'

11-Oct-2004 - Japanese pharmaceutical company, Takeda, has entered into collaboration with Bionumerik Pharmaceuticals, with the intention of marketing Bionumerik's Tavocept (dimensa), a chemoprotective drug that relieves the neurotherapy commonly associated with chemotherapy.

Takeda strikes deals to boost pipeline

05-Aug-2003 - Japanese drugmaker Takeda has entered into a €20 million, four-year research collaboration with Evotec Neurosciences, a subsidiary of Germany's Evotec OAI, to identify drug targets...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...